Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × Counseling × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 9 Neoplasms 4 Overweight 3 Obesity 3 Lung Neoplasms 3 Colorectal Neoplasms 3 Sleep Wake Disorders 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma 2 Leukemia 2 Hematopoietic and Lymphoid System Neoplasm 2 Hematologic Neoplasms 2 Fatigue 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2 Weight Loss 1 Uterine Cervical Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Obesity-Related Malignant Neoplasm 1 No Evidence of Disease 1 Neoplasm Metastasis 1 Motor Activity 1 Metastatic Pancreatic Adenocarcinoma 1 Leukemia, Myeloid, Acute 1 Intermittent Fasting 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Hematopoietic and Lymphatic System Neoplasm 1 Head and Neck Carcinoma 1

Interventions

pembrolizumab 119 Cisplatin 70 Cetuximab 52 Carboplatin 46 Nivolumab 39 Paclitaxel 38 Docetaxel 33 Radiotherapy 32 Radiotherapy, Intensity-Modulated 23 Fluorouracil 19 Magnetic Resonance Spectroscopy 18 Specimen Handling 16 Taxes 11 durvalumab 10 cemiplimab 10 Radiation 10 Platinum 10 Ipilimumab 10 1,2-diaminocyclohexaneplatinum II citrate 10 atezolizumab 9 Drug Therapy 9 Albumin-Bound Paclitaxel 9 tislelizumab 8 Surgical Procedures, Operative 7 Standard of Care 7 Chemoradiotherapy 7 Biopsy 7 130-nm albumin-bound paclitaxel 7 toripalimab 6 avelumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡